cidence of AKI evidenced by a .30% increase in postoperative serum creatinine measured on the third postoperative day.
The predominant mechanism of perioperative AKI is thought to be impaired perfusion; the initial insult appears to be hypoxic, followed by the production of reactive oxygen species and the activation of inflammatory mechanisms during reperfusion. 4 In endovascular aortic repair, additional causes of AKI include contrast-induced nephropathy, emboli to the renal vessels, or encroachment of the vascular stents on renal vessels. Contrast-induced nephropathy is often defined as a decrease in the estimated glomerular filtration rate (GFR) of ≥25% and/or an increase in serum creatinine of ≥25% within 96 h of exposure to contrast agents and in the absence of other causes, and is caused by a combination of medullary ischaemia and direct tubular toxicity. 5 Hydroxymethylglutaryl coenzyme A reductase inhibitors, also known as statins, reduce vascular events and death in hypercholesterolaemic patients and in patients with coronary artery disease. 6 7 In addition to their cholesterol-lowering effects, statins reduce endothelin secretion and rapidly increase nitric oxide production, thereby increasing flowmediated vasodilation and endothelial function. 8 Statins also scavenge free radicals, are anti-inflammatory, 9 and possess antithrombotic properties 10 -all of which are likely to be protective to the kidney. We thus tested the hypothesis that in patients undergoing endovascular aortic repair, the GFR decreases less in patients taking preoperative statins than in those who do not.
Methods
With Institutional Review Board approval, we included adults who had endovascular aortic repair at the Cleveland Clinic, whether abdominal or thoracic, between June 2005 and March 2007. Patients with pre-existing renal failure (as defined by requiring dialysis) and repeat endovascular aortic repair operations were excluded. Using the Perioperative Health Database System (PHDS) at the Cleveland Clinic, 501 consecutive patients were identified. Thirteen patients were removed due to missing serum creatinine measurements (n¼9), missing statin use data (n¼5), or both, leaving data from 488 patients available for analysis. The estimated GFR was determined using the modification of diet in renal disease equation since it provides a more clinically useful measure of kidney function than serum creatinine alone: This equation takes into account several factors that impact creatinine production including age, sex, and race. The equation does not require weight or height variables because the reported results are normalized to a typical adult value of 1.73 m 2 body surface area.
Our primary outcome was the postoperative GFR (after adjusting for a preoperative GFR as a covariable). Univariable assessment of the relationship between the statin use and the maximum postoperative GFR (measured over a period of 7 days) was performed using a linear regression model with the maximum postoperative GFR as the response variable and main effects for the preoperative GFR and statin use as predictors. However, this univariable assessment does not take into account potential confounding caused by differences in patient characteristics among those with and those without the preoperative statin use. Thus, for our primary analysis, we estimated the relationship between the statin use and the maximum postoperative GFR using a multivariable linear regression model, and this relationship served as the primary outcome of the study. This analysis of a continuous outcome provided .90% power to detect a true statin group difference in the mean postoperative GFR of at least 10 ml min 21 We also evaluated the incidence of a decrease in the GFR of .25% as a secondary endpoint, as this reduction in the GFR is used to define contrast nephropathy.
Our multivariable model was adjusted for the baseline GFR and other potentially confounding covariables, which were initially screened for univariable significance with statin use at the 0.40 level and then further selected using a stepwise criterion (significance-to-enter and significance-to-stay criteria set purposefully conservative at 0.4 and 0.3, respectively). Due to their importance, the patient weight, history of congestive heart failure, history of pulmonary disease, acetylcysteine use, diabetic status, total volume infused (red blood cells, crystalloids, and colloids) in millilitres per kilogram per hour, and baseline GFR were forced into the model. Contrast dye solution and dye volume were not considered for adjustment due to the high frequency of missing values for these two covariables.
SAS software version 9.1 (SAS Institute, Cary, NC, USA) and R software version 2.8.1 (The R Foundation for Statistical Computing, Vienna, Austria) were used for all statistical analysis and graphics.
Results
One hundred and ninety-two (39.3%) of the 488 patients studied were taking statin medications before operation. Adjusting only for baseline GFR, the estimated mean postoperative GFR was 0.2 [95% confidence interval (CI) (23.1, +3.4)] ml min 21 1.73 m 22 higher for statin users than that for non-statin users (P¼0.91; Fig. 1 ). However, those taking statins were, on average, older, more likely to be diabetic, less likely to be African American, more likely to have ischaemic heart disease, more likely to be given acetylcysteine, had a higher baseline serum creatinine concentration and lower baseline GFR, and were given more intraoperative fluids (Table 1) . These covariables, and also sex, diastolic arterial pressure, history of valvular heart disease, history of renal insufficiency, emergency status of case, intraoperative haematocrit, estimated intraoperative blood loss, and intraoperative red blood cell transfusion volume, were considered in our multivariable model using the procedure outlined above. Though estimated creatinine clearance rate met the screening criterion for consideration in our final model, it was not included due to its high correlation with the baseline GFR (r¼0.78). Twenty-three patients were excluded from the final model due to missing covariable data. After adjusting for the baseline GFR along with the other covariables (either forced into the model or included via the stepwise selection routine), no significant change in the postoperative GFR was associated with the statin use; the difference (95% CI) in the mean postoperative GFR (statins minus no statins) was estimated at 0. After accounting for all the other variables in the model, the statin use accounted for ,0.001% of the remaining variability in the postoperative GFR. A decrease in the GFR of .25% developed in 26 of 192 patients given statins before operation (13.5%) and in 36 of 296 patients who were not taking statins (12.2%), corresponding to a univariable odds ratio (95% CI) of 1.13 (0.66, 1.94) (statins vs no statins). Our primary model did not take into account the type and volume of i.v. contrast dye as these data were unavailable for 50% of the patients studied. However, in a confirmatory, stepwise logistic model on the subset of patients where i.v. contrast dye and volume were available (n¼208 included in the model), the difference (95% CI) in the mean postoperative GFR (statins minus no statins) was estimated at 2.5 (21.4, +6.5) ml min 21 1.73 m 22 (P¼0.21).
Since patients taking statins before operation were different on several baseline and intraoperative factors than those not taking statins before operation (Table 1) , we used propensity matching to confirm our results (propensity scores estimated using stepwise logistic regression-first excluding i.v. dye and volume and then including these variables-and patients were subsequently matched via a greedy matching algorithm using a maximum distance criterion of 0.05 propensity score units). As a result of the propensity matching, covariables were better balanced (data not shown). In the propensity model excluding i.v. dye and volume, 131 matched pairs were analysed (total n¼262); the difference (95% CI) in the mean postoperative GFR (statins minus no statins) was estimated at 1. 
Discussion
Preoperative statin therapy did not preserve the GFR in our patients undergoing endovascular aortic repair. Our results are in agreement with a recent meta analysis showing that statin therapy did not reduce the incidence of contrastinduced nephropathy after coronary angiography. 13 On the other hand, our results contrast with those reported by Khanal and colleagues 14 and Patti and colleagues 15 who identified a significantly lower incidence of contrast nephropathy in patients undergoing percutaneous coronary interventions who took statins. However, neither study reported the perioperative hydration status. This is a potentially important omission since serum creatinine increases less in patients given i.v. fluid supplementation before exposure to contrast media. 11 Consistent with that observation, negative fluid balance is an established risk for the development of contrast nephropathy. 16 We used a 25% reduction in the GFR as being more sensitive than serum creatinine alone to changes in renal function since the GFR may be reduced by more than 75% before serum creatinine becomes abnormal. 17 Furthermore, a 25% reduction in the GFR is included in the RIFLE criterion, a consensus definition for acute renal failure published by the Acute Dialysis Quality Initiative Group. 18 Welten and colleagues 19 reported that statins did not reduce the incidence of AKI after open vascular surgery, although the statin use in their study was associated with early recovery of kidney injury. In patients undergoing endovascular aortic repair, statins only showed a protective effect on renal function in the subset of patients undergoing endovascular aortic repair (EVAR) with suprarenal fixation, which the authors attributed to statins' plaque stabilization (5) 28 (5) Female sex 82 (28) 45 (23) Diabetes* 24 (8) 44 (23) African-American race* 11 23 (8) 5 (3) Baseline diastolic BP (mm Hg) 48 75 (14) 77 (21) Baseline systolic BP (mm Hg) 42 143 (28) 142 (27) Past medical history Stroke 17 (6) 8 (4) Ischaemic heart disease* 125 (42) 118 (62) Valvular heart disease 19 (6) 18 (9) Atrial fibrillation 26 (9) 16 (8) Hypertension 138 (47) 95 (50) Congestive heart failure 29 (10) 10 (5) Pulmonary disease 77 (26) 38 (20) Renal properties. Statins did not improve short-term renal outcomes in patients with infrarenal fixation and did not reduce the worsening of renal function at 6 and 12 months after operation. In our study, we hypothesized that contrast-induced nephropathy might be a cause for the GFR decline in patients undergoing EVAR, since AKI caused by ischaemiareperfusion injury is attenuated by EVAR compared with open abdominal aortic aneurysm repair. 20 We also evaluated the intraoperative anaesthesia records and operative notes of patients with a reduction in the GFR of .25% to rule out ischaemic and surgical causes (malpositioned vascular stents) as the aetiology of postoperative reduction in the GFR. However, the type and dose of contrast were not standardized and in many cases not recorded, and other causes of post-EVAR AKI, such as emboli to the renal vessels from plaque rupture caused by intra-aortic manipulation, cannot be entirely excluded. The multifactorial aetiology of AKI after EVAR may offer another explanation of why single pharmacological interventions have not conferred renoprotective effects in this and other studies. The lack of renal protective effects of statins in our study should not preclude from their perioperative use. Statins have been shown to reduce all-cause and cardiovascular mortality in patients undergoing vascular surgery. 21 Several pharmacological strategies for reducing the risk of AKI or contrast nephropathy have recently been evaluated. Acetylcysteine has been shown to reduce the incidence of contrast nephropathy in several studies. 22 23 However, recent meta-analyses have concluded that treatment produced with acetylcysteine is only marginally protective. 24 25 Our results are consistent with this conclusion since the use of acetylcysteine was not independently associated with the maintenance of the postoperative GFR in our patients.
Various direct and indirect vasodilators (e.g. atrial natriuretic peptide, calcium-channel blockers, angiotensinconverting enzyme inhibitors, and endothelin receptor antagonists) have been studied for the reduction in contrast nephropathy with limited success. 26 -29 Furthermore, forced diuresis with furosemide and mannitol has been proven to be ineffective for reducing the incidence of contrast nephropathy 30 -and may even be harmful by creating a negative fluid balance. Our results are thus consistent with previous studies, showing that various potentially protective agents have little or no clinical benefit. It is nonetheless worth considering reasons why our results may have been negative. Verma and colleagues 31 showed in an experimental model that pravastatin attenuates cell injury only when serum concentration exceeds 10 mM. Typical clinical concentrations of statins are 25 -50 ng ml 21 . 31 It is possible that statins in our patients were diluted by aggressive hydration to the point of being ineffective. Of course, it is equally possible that post-EVAR AKI is mediated by pathways that are not ameliorated by statins' pleiotropic properties. At the very least, our results suggest that factors such as the baseline GFR and age may be more important determinants of the postoperative GFR than the use of preoperative statin therapy. The preoperative GFR alone accounted for 60% of postoperative GFR variability, demonstrating that preoperative renal reserve may be more important in predicting renal outcomes than any single 'renal protective' intervention. Consistent with this theory are numerous previous studies, showing that high preoperative serum creatinine is significantly associated with contrast nephropathy. 16 32 33 Age has also been consistently demonstrated to be an independent risk factor for contrast nephropathy. 34 Other covariates associated with a statistically significant decline in the GFR in our study included a history of congestive heart failure (probably mediated through a reduction in cardiac output and renal blood flow, but may also be related to the concomitant use of diuretics). Even though the number of emergency cases in our study was small (n¼21), there was a highly significant association between emergency surgery and lower mean postoperative estimated GFR compared with elective cases. Diabetes mellitus was not significantly associated with a lower mean postoperative GFR in our study. This may have been the result of established perioperative algorithms to achieve perioperative euglycaemia, but may also be due to the fact that diabetic status is already reflected in the presence of chronic kidney disease which was significantly associated with a lower mean postoperative GFR.
Our registry does not include the type and dose of preoperative statins that our patients used. This information might be important because recent reports identify differences in anti-inflammatory effects among various statins. 35 As with any observational study, our results are subject to potential selection bias, confounding, and measurement bias. In addition, our primary model did not account for the type and volume of contrast dye as these data were unavailable in 50% of the study patients, which may have influenced our results. We attempted to limit these sources of error by using propensity matching. While a randomized controlled trial may reduce these biases, most patients currently presenting for vascular surgery are already taking statins for primary and secondary prevention against cardiovascular events, making intervention with a statin vs no statin trial hard to conduct.
In summary, our results do not support the theory that the GFR decreases less in patients who take preoperative statins than in those who do not.
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